+1-518-618-1030 866 - 552 - 3453 USA-Canada Toll Free
Published Date: 2016-02-18Number of Pages: 89

Oxygen Therapy Devices Market (Product Type: Oxygen Source Equipment & Oxygen Delivery Devices; Applications: Chronic Obstructive Pulmonary Disease, Asthma, Obstructive Sleep Apnea, Respiratory Distress Syndrome, Cystic Fibrosis, Pneumonia) - North America Industry Analysis, Size, Share, Growth, Trends and Forecast 2015 - 2023

Oxygen therapy has emerged to be one of the most potential options used for treating various respiratory diseases due to its definitive, supplementary or palliative role. Oxygen therapy devices are used for a wide range of applications in the treatment of different diseases including chronic obstructive pulmonary disease, obstructive sleep apnea, respiratory distress syndrome, asthma, cystic fibrosis, and pneumonia. COPD is the largest application of oxygen therapy devices, as the prevalence of respiratory diseases is rapidly increasing. According to the Centers for Disease Control and Prevention, approximately 39.0 million people in the U.S. had evidence of chronic obstructive pulmonary disease in 2011. Likewise, approximately 5.8% of the population of New Mexico is affected by COPD. Kentucky accounted for the highest COPD cases, approximately 9.3%, in 2011, followed by Alabama with 9.1% of the total population. Moreover, rising burden of health care expenditure on governments and private players has induced manufacturers to introduce oxygen therapy devices that are patient friendly, portable, and cost effective.

The oxygen therapy devices market in North America is segmented by product type into oxygen source equipment and oxygen delivery devices. Oxygen source equipment is further sub-segmented into oxygen cylinders, oxygen concentrators and liquid oxygen devices. Oxygen concentrators accounted for the largest share of more than 42.4% of the overall North America oxygen therapy devices market in 2014. However, liquid oxygen devices are expected to grow at the highest CAGR during the forecast period through 2015 to 2023. Factors such as low per unit cost of liquid oxygen system, power saving, and maximum mobility are accelerating the growth of the liquid oxygen devices in North America. Additionally, easy-to-use features and easy-to-carry liquid oxygen devices are expected to drive market growth during the forecast period. Better storage capacity of liquid oxygen devices as compared to other oxygen source equipment is further expected to drive the growth of the segment. 

Similarly, the oxygen delivery devices market is further sub-segmented into simple oxygen masks, nasal cannula, Venturi masks, non-rebreather masks, bag valve masks and CPAP (continuous positive airway pressure) masks. Venturi masks are estimated to grow at an approximate CAGR of above 7% throughout the forecast period. Technological factors such as delivery of supplemental oxygen at an accurate and fixed concentration with minimum discomfort are driving the growth of the segment. Furthermore, based on applications, the oxygen therapy devices market is segmented into chronic obstructive pulmonary disease (COPD), asthma, respiratory distress syndrome, obstructive sleep apnea, pneumonia and cystic fibrosis. The largest application for oxygen therapy devices is COPD, as the prevalence of fatal respiratory diseases is rapidly gaining momentum. Factors that accentuated the growth of the segment are high prevalence of COPD across North America and growing patient preference to opt for oxygen therapy as their first treatment option, thereby propelling the growth of the application of oxygen therapy in COPD treatment in North America. 

Geographically, the U.S. constituted the largest market share in the North America oxygen therapy devices market in 2014. Factors that have assisted the growth of the oxygen therapy devices market in the U.S. are rising prevalence of life-threatening repiratory diseases and developed healthcare infrastructures. Furthermore, technological developments in the field of medical devices and increasing public awareness regarding oxygen therapy are also boosting the growth of the oxygen therapy devices market in the U.S. 

At present,  some of the major companies involved in the North America oxygen therapy devices market are Respironics, Inc. (a Philips company), Fisher & Paykel Healthcare Limited, Teleflex Incorporated, Invacare Corporation, AirSep Corporation, CareFusion Corporation, DeVilbiss Healthcare, MAQUET Holding B.V. & Co. KG, and ResMed, Inc.

 

north-america-oxygen-therapy-devices-market

 


1. Preface
    1.1. Report Description
    1.2. Market Segmentation
    1.3. Research Methodology

2. Executive Summary
    2.1. North America Oxygen Therapy Devices: Market Snapshot
    2.2. North America Oxygen Therapy Devices Market Share, by Application, 2014 (US$ Mn)
    2.3. North America Oxygen Therapy Devices Market Share, by Product Type, 2014 (US$ Mn)

3. Industry Analysis : North America Oxygen Therapy Devices
    3.1. Introduction and Market Definition
    3.2. Drivers
          3.2.1. Rise in incidence of COPD and other respiratory diseases
          3.2.2. Increasing patient preference for portable home oxygen therapy equipment
    3.3. Restraints
          3.3.1. Patient concerns associated with complication of long-term oxygen therapy
    3.4. Opportunities
          3.4.1. Technological advancements in the field of respiratory care to spur market growth
          3.4.2. Increasing government initiatives toward improving respiratory care
    3.5. Porter’s Five Forces Analysis 
    3.6. Market Attractiveness Analysis 
          3.6.1. North America Oxygen Therapy Devices Market, by Product Type
          3.6.2. North America Oxygen Therapy Devices Market, by Country
    3.7. Prescription Analysis
    3.8. Competitive Landscape
          3.8.1. North America Oxygen Therapy Devices Market Share, by Key Players, 2014
          3.8.2. Brand Positioning Maps: North America Oxygen Delivery Devices
          3.8.3. Brand Positioning Maps: North America Oxygen Source Equipment
    3.9. Economic Outlook & Geopolitical Analysis 
    3.10. Reimbursement Policies 

4. Market Segmentation – By Product Type
    4.1. Introduction
    4.2. North America Oxygen Therapy Devices Market Revenue, by Product Type, 2013–2023 (US$ Mn)
    4.3. North America Oxygen Source Equipment, By Type, 2013–2023 (US$ Mn)
          4.3.1. North America Oxygen Cylinders Market Revenue, by Country, 2013–2023, (US$ Mn)
          4.3.2. North America Oxygen Concentrators Market Revenue, by Country, 2013–2023, (US$ Mn)
          4.3.3. North America Liquid Oxygen Devices Market Revenue, by Country, 2013–2023, (US$ Mn)
    4.4. North America Oxygen Delivery Devices, By Type, 2013–2023, (US$ Mn)
          4.4.1. North America Simple Oxygen Mask Revenue, by Country, 2013–2023, (US$ Mn)
          4.4.2. North America Venturi Mask Market Revenue, by Country, 2013–2023, (US$ Mn)
          4.4.3. North America Nasal Cannula Market Revenue, by Country, 2013–2023 (US$ Mn)
          4.4.4. North America Non-Rebreather Market Revenue, by Country, 2013–2023 (US$ Mn) 
          4.4.5. North America Bag Valve Mask Market Revenue, by Country, 2013–2023, (US$ Mn)
          4.4.6. North America CPAP Mask Market Revenue, by Country, 2013–2023, (US$ Mn)

5. Market Segmentation – By Application
    5.1. Introduction    
    5.2. North America Oxygen Therapy Devices Market Revenue, by Application, 2013–2023 (US$ Mn) 
          5.2.1. North America Oxygen Therapy Devices Market Revenue in COPD, 2013–2023 (US$ Mn) and Analysis
          5.2.2. North America Oxygen Therapy Devices Market Revenue in Asthma, 2013–2023 (US$ Mn) and Analysis
          5.2.3. North America Oxygen Therapy Devices Market Revenue in Obstructive Sleep Apnea, 2013–2023 (US$ Mn) and Analysis
          5.2.4. North America Oxygen Therapy Devices Market Revenue in Respiratory Distress Syndrome, 2013–2023 (US$ Mn) and Analysis
          5.2.5. North America Oxygen Therapy Devices Market Revenue in Cystic Fibrosis, 2013–2023 (US$ Mn) and Analysis
          5.2.6. North America Oxygen Therapy Devices Market Revenue in Pneumonia, 2013–2023 (US$ Mn) and Analysis

6. Recommendations

7. Company Profiles
    7.1. Chart Industries (AirSep Corporation)
    7.2. CareFusion Corporation
    7.3. DeVilbiss Healthcare LLC
    7.4. Fisher & Paykel Healthcare Limited
    7.5. Invacare Corporation 
    7.6. MAQUET Holding B.V. & Co. KG.
    7.7. Koninklijke Philips N.V.
    7.8. ResMed
    7.9. Smiths Medical
    7.10. Teleflex Incorporated

This report on the North America oxygen therapy devices market studies the current and future prospects of the market. North America oxygen therapy devices market is segmented on the basis of products and application. On the basis of products the oxygen therapy devices market is segmented into oxygen source equipment and oxygen delivery devices. Rise in COPD and asthma cases and significant technological advancements in the field of respiratory devices have triggered the growth of the oxygen therapy devices market. Additionally, high risk of lung damage due to tobacco consumption, pollution, and occupational hazards across the globe is anticipated to augment the market during the forecast period. Moreover, easy-to-use and portable devices are likely to boost the growth of the market.

The North America oxygen therapy devices market report comprises an elaborate executive summary, which includes a market snapshot that provides information about various segments and sub-segments of the market. It also provides information and data analysis of the North America oxygen therapy devices market with respect to market segments based on the product type, application and geographic analysis.

Based on product type, the North America oxygen therapy devices market has been segmented into two major categories: oxygen source equipment and oxygen delivery devices. The oxygen source equipment segment is further categorized into oxygen cylinders, oxygen concentrators and liquid oxygen devices. Moreover, the oxygen delivery devices segment has been sub-segmented into simple oxygen mask, nasal cannula, Venturi mask, non-rebreather mask, bag valve mask, and CPAP mask.  On the basis of application, the market is segmented into chronic obstructive pulmonary disease, asthma, obstructive sleep apnea, respiratory distress syndrome, cystic fibrosis and pneumonia. Demand for oxygen delivery devices is likely to increase due to rising incidence of COPD among the geriatric population and advancement of novel therapeutic devices for oxygen therapy. The market segments have been extensively analyzed based on usefulness, efficacy, revenue, and geographical coverage. The market size and forecast in terms of US$ Mn for each segment has been provided for the period from 2013 to 2023. The report also provides the compound annual growth rate (CAGR %) for each market segment for the forecast period from 2015 to 2023, considering 2014 as the base year.

Geographically, the North America oxygen therapy devices market has been segmented into two countries: the United States and Canada. The market size and forecast for each of these countries has been provided for the period from 2013 to 2023, along with their respective CAGRs for the forecast period from 2015 to 2023, considering 2014 as the base year. The research study also covers the competitive scenario in these regions. A detailed qualitative analysis of factors responsible for driving and restraining the growth of the market and future opportunities has been provided in the market overview section. This section of the report also provides market attractiveness analysis, Porter’s Five Forces analysis, and market share analysis by key players, thus presenting a thorough analysis of the overall competitive scenario in the North America oxygen therapy devices market.

A list of recommendations has been provided for new entrants as well as existing market players to assist them in taking strategic initiatives to establish a strong presence in the market. The report also profiles major players in the North America oxygen therapy devices market based on various attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments. Major players profiled in this report include CareFusion Corporation, DeVilbiss Healthcare, LLC, Fisher & Paykel Healthcare Limited, MAQUET Holding B.V. & Co. KG, Smiths Medical, Teleflex Incorporated, Invacare Corporation, Philips Respironics, Inc., and AirSep Corporation

North America oxygen therapy devices market is segmented as follows:

North America Oxygen Therapy Devices Market, by Product Type

  • Oxygen Source Equipment
    • Oxygen Cylinders
    • Oxygen Concentrators
    • Liquid Oxygen Devices
  • Oxygen Delivery Devices
    • Simple Oxygen Mask
    • Nasal Cannula
    • Venturi Mask
    • Non-rebreather Mask
    • Bag Valve mask
    • CPAP Mask

North America Oxygen Therapy Devices Market, by Applications

  • Chronic Obstructive Pulmonary Disease (COPD)
  • Asthma
  • Obstructive Sleep Apnea
  • Respiratory Distress Syndrome (RDS)
  • Cystic Fibrosis
  • Pneumonia

North America Oxygen Therapy Devices Market, by Geography

  • United States
  • Canada


 
 
Back To Top